ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.1359-31_1359-23delinsCGGCT

dbSNP: rs879254876
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel RCV000238072 SCV004022444 uncertain significance Hypercholesterolemia, familial, 1 2023-03-20 reviewed by expert panel curation The NM_000527.5(LDLR):c.1359-31_1359-23delinsCGGCT variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, PP4, PS3_supporting) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: - PM2: This variant is absent from gnomAD (gnomAD v2.1.1). - PP4: Variant meets PM2. Identified in 1 FH case from PMID: 8872473 meeting Simon-Broome criteria of possible FH , after alternative causes of high cholesterol were excluded. - PS3: Level 3 assay: PMID 8872473: Heterozygous patient's Epstein-Barr virus transformed lymphoblasts, RNA assays; Heterologous cells (COS), RNA assays: Retention of intron 9 (p.Ser453Argfs*2) ---- functional study is consistent with damaging effect.
LDLR-LOVD, British Heart Foundation RCV000238072 SCV000295386 pathogenic Hypercholesterolemia, familial, 1 2016-03-25 criteria provided, single submitter literature only
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge RCV000238072 SCV000599371 uncertain significance Hypercholesterolemia, familial, 1 2016-03-01 criteria provided, single submitter curation
Color Diagnostics, LLC DBA Color Health RCV001525939 SCV001736158 uncertain significance Familial hypercholesterolemia 2023-10-25 criteria provided, single submitter clinical testing This variant deletes 9 nucleotides and inserts 5 nucleotides, CGGCT, in intron 9 of the LDLR gene. An RNA study using patient-derived lymphoblasts and a minigene assay have shown that this variant causes a retention of intron 9 sequence in mRNA and utilization of cryptic acceptor sites in exon 10, resulting in a frameshift and premature translation stop signal (PMID: 8872473). This variant has been reported in one individual affected with familial hypercholesterolemia (PMID: 8872473). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Although there is a suspicion for a pathogenic role, the available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002379066 SCV002690265 likely pathogenic Cardiovascular phenotype 2018-10-18 criteria provided, single submitter clinical testing The c.1359-31_1359-23delGCGCTGATGinsCGGCT intronic variant, located in intron 9 of the LDLR gene, results from an in-frame from the deletion of 9 nucleotides and the insertion of 5 nucleotides at nucleotide position 1359. This alteration has been reported in an individual with familial hypercholesterolemia (FH), and RNA studies have demonstrated that this alteration leads to the retention of intron 9 and incorporation of a premature stop codon (Webb JC et al. Hum. Mol. Genet., 1996 Sep;5:1325-31). These nucleotide positions are not well conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum RCV000238072 SCV000606406 benign Hypercholesterolemia, familial, 1 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.